Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the immunogenicity and clinical utility of recombinant Ad5 (rAd5) vector-based vaccines for human immunodeficiency virus type 1 and other pathogens. A potential solution to this problem...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lemckert, Angelique A. C., Sumida, Shawn M., Holterman, Lennart, Vogels, Ronald, Truitt, Diana M., Lynch, Diana M., Nanda, Anjali, Ewald, Bonnie A., Gorgone, Darci A., Lifton, Michelle A., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2005
Aiheet:
Pathogenesis and Immunity
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1181575/
https://ncbi.nlm.nih.gov/pubmed/16014931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.15.9694-9701.2005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia